GHRP-6 and MK-677 Interaction

Monitor
Mechanism-based 51% confidence

GHRP-6 and MK-677 have an interaction requiring monitoring for interaction with 51% confidence. Both GHRP-6 and MK-677 stimulate the ghrelin receptor. Additive GH release may increase side effects (water retention, joint pain, blood glucose elevation). Consider using one at a time or reducing doses. Both compounds affect the gi tract and pituitary, so monitoring these systems is recommended.

Compound Profiles

GHRP-6

Growth Hormone Releasing Peptide-6 | Hexapeptide GHS

GHRP-6 binds to the growth hormone secretagogue receptor (GHS-R1a), the same receptor activated by ghrelin. This initiates a signaling cascade in the hypothalamus and pituitary gland, triggering a rapid pulse of natural GH secretion.

Half-life: 15-60 minutes Typical dose: 100-300 mcg per injection growth hormone, weight loss
ghrelin receptorigf1 carcinogenic riskinsulin disruptingprolactin elevatingteratogenic
View full profile

MK-677

Ghrelin Receptor Agonist | Oral Growth Hormone Secretagogue

Selectively binds GHS-R1a receptors in hypothalamus and pituitary, triggering pulsatile growth hormone release while maintaining natural circadian patterns..

Half-life: ~24 hours Typical dose: Start 12.5mg daily, increase to 25mg based on tolerance growth hormone, weight loss, sleep
ghrelin receptor blood pressure raisingcarcinogenic riskhepatotoxicinsulin disrupting
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low
Brain
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (GHRP-6, MK-677). Monitor accordingly.
2x 2 compounds affect insulin sensitivity (GHRP-6, MK-677). Monitor fasting glucose and HbA1c.
2x 2 compounds share the teratogenic safety flag (GHRP-6, MK-677). Monitor accordingly.

Frequently Asked Questions

Can I take GHRP-6 with MK-677?

Yes, but with caution. Both GHRP-6 and MK-677 stimulate the ghrelin receptor. Additive GH release may increase side effects (water retention, joint pain, blood glucose elevation). Consider using one at a time or reducing doses. Regular monitoring is advised.

Is GHRP-6 and MK-677 safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.

What are the interactions between GHRP-6 and MK-677?

Both GHRP-6 and MK-677 stimulate the ghrelin receptor. Additive GH release may increase side effects (water retention, joint pain, blood glucose elevation). Consider using one at a time or reducing doses. This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.

How should I time GHRP-6 and MK-677?

GHRP-6 has a half-life of 15-60 minutes and MK-677 has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: GHRP-6 vs MK-677

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.